[Skip to Content]
[Skip to Content Landing]
Citations 0
Capitol Health Call
August 10, 2005

Antianxiety Inclusion

JAMA. 2005;294(6):673. doi:10.1001/jama.294.6.673-c

Lawmakers in the House of Representatives are considering a bill that would add coverage of antianxiety medications to the Medicare prescription drug benefit set to begin in January. The benefit currently excludes benzodiazepines from coverage, which could put patients at risk and limit physicians’ treatment options.

Currently, all states provide some coverage for benzodiazepines for low-income seniors under Medicaid; after the national prescription drug benefits plan goes into effect, these individuals will be covered by Medicare and states may eliminate coverage.